Abstract
The authors report two clinical trials concerning chemotherapy and immunotherapy combined in the treatment of primary and metastatic brain tumors. In the first study Bacillus Calmette-Guerin (BCG) and in the second levamisole (LMS) were utilized as immunostimulating agents. Chemotherapy was performed with BCNU and CCNU in association with surgery and/or radiotherapy. An immunological response was obtained but immunotherapy failed to demonstrate any significant effect on survival.
| Original language | English |
|---|---|
| Pages (from-to) | 19-24 |
| Number of pages | 6 |
| Journal | Journal of Neurosurgical Sciences |
| Volume | 29 |
| Issue number | 1 |
| Publication status | Published - 1985 |
Fingerprint
ASJC Scopus subject areas
- Clinical Neurology
Cite this
Knerich, R., Robustelli della Cuna, G., Butti, G., Pavesi, L., Adinolfi, D., Preti, P., & Locatelli, D. (1985). Chemotherapy plus immunotherapy for patients with primary and metastatic brain tumors. Journal of Neurosurgical Sciences, 29(1), 19-24.